Esophageal cancer is a unique and complex heterogeneous malignancy, with substantial
tumor heterogeneity: at the cellular levels, tumors are composed of tumor and stromal …

Background The advent of next-generation computed tomography (CT)-and magnetic
resonance imaging (MRI) opened many new perspectives in the evaluation of tumor …

Background: Orlistat is an antiobesity drug approved by the US Food and Drug
Administration (FDA) with potential antitumor activity against a few malignant tumors …

Multiple endocrine neoplasia 1 (MEN1) syndrome, a disease arising from a genetic
predisposition to tumor development caused by MEN1 loss-of-function mutations, is …

Purpose Somatostatin receptor (SSTR) imaging features are predictive of treatment outcome
for neuroendocrine tumor (NET) patients receiving peptide receptor radionuclide therapy …

This study investigates the potential of a machine learning classifier using dual‐energy
computed tomography (DECT) radiomics to differentiate between malignant pancreatic …

With the flourishing development of precision medicine, theranostics, generally recognized
as the integration of diagnosis and treatment, has emerged as a prominent trend in clinical …

Cancer treatment response assessment is particularly challenging in the setting of
metastatic cancer in part because patients can present with hundreds of metastatic lesions …

Background This study aimed to identify new protein markers that can evaluate the
metastatic ability of Pancreatic neuroendocrine tumors (PanNETs) and predict prognosis …